Northwest Biotherapeutics Acquires Advent BioServices Ltd.

Takeda Acquires Adaptate Biotherapeutics

January 10, 2022

Biotechnology

Takeda Pharmaceutical Company Limited has exercised its option to acquire Adaptate Biotherapeutics, a UK biotechnology spin-out focused on antibody-based γδ T cell engager therapies for solid tumors. The acquisition gives Takeda Adaptate’s antibody-based γδ T cell engager platform and preclinical pipeline to strengthen Takeda’s immuno-oncology capabilities and accelerate development of Vδ1‑targeting therapies.

Bayer AG Acquires Asklepios BioPharmaceutical (AskBio)

October 26, 2020

Biotechnology

Bayer AG agreed to acquire U.S.-headquartered Asklepios BioPharmaceutical (AskBio), adding AskBio's AAV-based gene therapy platform, IP and CDMO manufacturing capabilities to Bayer’s emerging cell and gene therapy unit. Bayer will pay $2.0 billion upfront plus up to $2.0 billion in potential milestone payments; existing minority shareholders TPG Capital and Vida Ventures supported the transaction.

Advent International and Warburg Pincus Acquire Baxter's BioPharma Solutions to Form Simtra BioPharma Solutions

October 2, 2023

Pharmaceuticals

Advent International and Warburg Pincus completed the acquisition of Baxter International's BioPharma Solutions (BPS) business for $4.25 billion in cash, creating a standalone CDMO named Simtra BioPharma Solutions. Simtra will operate manufacturing sites in Bloomington, Indiana and Halle, Germany, establish a corporate headquarters in New Jersey, and employ approximately 1,700 people to provide sterile contract manufacturing and parenteral delivery services to pharma and biotech customers.

Danforth Advisors Acquires BW Health Group

May 29, 2024

Healthcare Services

Danforth Advisors has acquired BW Health Group, a commercialization and product-launch services platform serving small- and mid-sized life science companies. The deal adds commercial readiness, launch planning and biopharma marketing capabilities (Benchworks and BW Consulting) to Danforth's integrated life-science advisory and operational services offering.

Discovery Life Sciences Acquires East West Biopharma

November 9, 2020

Healthcare Services

Discovery Life Sciences acquired East West Biopharma, a European human biospecimen contract research organization with a large biocollection network in Ukraine. The deal expands Discovery’s biospecimen collection and clinical site footprint across Europe, strengthening its global position as a leading provider of biospecimen and related scientific services.

BioIVT Acquires ZenBio

August 21, 2024

Healthcare Services

BioIVT has acquired ZenBio, a Durham-based provider of advanced cell products and biospecimen services, to expand its skin-based expertise, primary cell and exosome isolation capabilities, and blood product offerings for pharmaceutical and cosmetics research. The deal strengthens BioIVT's service portfolio and complements recent integrations to accelerate support for drug discovery and cosmeceutical development; financial terms were not disclosed.